Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE ANALYSIS
5.2 PORTER’S FIVE FORCES
5.3 KEY STRATEGIC INITIATIVES
6 INDUSTRY INSIGHTS
6.1 DEMOGRAPHIC TRENDS
6.2 INTERVIEWS WITH MANUFACTURING COMPANIES
6.3 INTERVIEWS WITH TECHNICIANS
6.4 OTHER KOL SNAPSHOTS
6.5 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET ANALYSIS
7 REGULATORY FRAMWORK
8 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY PRODUCT AND SERVICES
8.1 OVERVIEW
8.2 PRODUCT
8.2.1 X-RAY SYSTEM
8.2.1.1. BY TYPE
8.2.1.1.1. COMPUTED RADIOGRAPHY (CR)
8.2.1.1.1.1 MARKET VALUE (USD MILLION)
8.2.1.1.1.2 MARKET VOLUME (UNIT)
8.2.1.1.1.3 AVERAGE SELLING PRICE (USD)
8.2.1.1.2. DIRECT RADIOGRAPHY (DR)
8.2.1.1.2.1 MARKET VALUE (USD MILLION)
8.2.1.1.2.2 MARKET VOLUME (UNIT)
8.2.1.1.2.3 AVERAGE SELLING PRICE (USD)
8.2.1.1.3. OTHERS
8.2.1.2. BY APPLICATION
8.2.1.2.1. GENRAL RADIOGRAPHY
8.2.1.2.2. MAMMOGRAPHY
8.2.1.2.3. DENTISTRY
8.2.1.2.4. OTHERS
8.2.1.3. BY MODALITY
8.2.1.3.1. STATIONARY
8.2.1.3.2. PORTABLE/MOBILE
8.2.2 MRI SYSTEM
8.2.2.1. BY TYPE
8.2.2.1.1. OPEN
8.2.2.1.1.1 LOW FIELD
8.2.2.1.1.2 HIGH FIELD
8.2.2.1.1.3 ULTRA HIGH FIELD
8.2.2.1.2. CLOSED
8.2.2.1.2.1 LOW FIELD
8.2.2.1.2.2 HIGH FIELD
8.2.2.1.2.3 ULTRA HIGH FIELD
8.2.2.2. BY MODALITY
8.2.2.2.1. STATIONARY
8.2.2.2.2. PORTABLE/MOBILE
8.2.3 ULTRASOUND SYSTEM
8.2.3.1. BY TYPE
8.2.3.1.1. DIAGNOSTIC ULTRASOUND
8.2.3.1.1.1 2D ULTRASOUND
8.2.3.1.1.2 3D AND 4D ULTRASOUND
8.2.3.1.1.3 DOPPLER ULTRASOUND
8.2.3.1.2. THERAPEUTIC ULTRASOUND
8.2.3.1.2.1 SHOCKWAVE LITHOTRIPSY
8.2.3.1.2.2 HIGH INTENSITY FOCUSED ULTRASOUND
8.2.3.2. BY DISPLAY
8.2.3.2.1. BLACK AND WHITE
8.2.3.2.2. COLORED
8.2.3.3. BY MODALITY
8.2.3.3.1. STATIONARY
8.2.3.3.2. PORTABLE/MOBILE
8.2.4 CT SYSTEM
8.2.4.1. BY TYPE
8.2.4.1.1. CONVENTIONAL CT SCANNERS
8.2.4.1.2. SPECTRAL CT SCANNERS
8.2.4.2. BY TECHNOLOGY
8.2.4.2.1. HIGH-SLICE CT
8.2.4.2.2. MID-SLICE CT
8.2.4.2.3. LOW-SLICE CT
8.2.4.2.4. CONE BEAM CT (CBCT)
8.2.4.3. BY MODALITY
8.2.4.3.1. STATIONARY
8.2.4.3.2. PORTABLE/MOBILE
8.2.5 NUCLEAR IMAGING
8.2.5.1. SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)
8.2.5.1.1. HYBRID SPECT SYSTEMS
8.2.5.1.2. STANDALONE SPECT SYSTEMS
8.2.5.2. HYBRID PET
8.2.5.3. PLANAR SCINTIGRAPHY
8.2.6 OTHERS
8.3 SERVICES
8.3.1 X-RAY
8.3.2 MAGNETIC RESONANCE IMAGING
8.3.3 ULTRASOUND
8.3.4 COMPUTED TOMOGRAPHY
8.3.5 NUCLEAR IMAGING
8.3.6 OTHERS
9 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY VISUALIZATION
9.1 OVERVIEW
9.2 2D
9.3 3D/4D
9.4 OTHERS
10 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 DIAGNOSTICS
10.2.1 MAGNETIC RESONANCE IMAGING (MRI)
10.2.1.1. OPEN MRI SYSTEMS
10.2.1.2. CLOSED MRI SYSTEMS
10.2.2 COMPUTED TOMOGRAPHY (CT)
10.2.2.1. HIGH-SLICE
10.2.2.2. MID-SLICE
10.2.2.3. LOW-SLICE
10.2.3 X-RAY
10.2.4 ULTRASOUND SYSTEM
10.2.5 MOLECULAR IMAGING
10.2.5.1. SPECT SYSTEMS
10.2.5.2. PET SYSTEMS
10.2.6 OTHERS
10.3 INTERVENTIONAL
10.3.1 X-RAY
10.3.2 ULTRASOUND SYSTEMS
10.3.3 COMPUTED TOMOGRAPHY
10.3.4 MAGNETIC RESONANCE IMAGING
10.3.5 NUCLEAR IMAGING
11 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY MODALITY
11.1 OVERVIEW
11.2 STATIONARY
11.3 PORTABLE/MOBILE
12 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CARDIOLOGY
12.2.1 X-RAY
12.2.2 MRI
12.2.3 ULTRASOUND
12.2.4 CT
12.2.5 NUCLEAR IMAGING
12.2.6 OTHERS
12.3 ONCOLOGY
12.3.1 X-RAY
12.3.2 MRI
12.3.3 ULTRASOUND
12.3.4 CT
12.3.5 NUCLEAR IMAGING
12.3.6 OTHERS
12.4 MAMMOGRAPHY
12.4.1 X-RAY
12.4.2 MRI
12.4.3 ULTRASOUND
12.4.4 CT
12.4.5 OTHERS
12.5 GYNECOLOGY
12.5.1 X-RAY
12.5.2 MRI
12.5.3 ULTRASOUND
12.5.4 CT
12.5.5 NUCLEAR IMAGING
12.5.6 OTHERS
12.6 NEUROLOGY
12.6.1 X-RAY
12.6.2 MRI
12.6.3 ULTRASOUND
12.6.4 CT
12.6.5 NUCLEAR IMAGING
12.6.6 OTHERS
12.7 UROLOGY
12.7.1 X-RAY
12.7.2 MRI
12.7.3 ULTRASOUND
12.7.4 CT
12.7.5 NUCLEAR IMAGING
12.7.6 OTHERS
12.8 MUSCULOSKELETAL
12.8.1 X-RAY
12.8.2 MRI
12.8.3 ULTRASOUND
12.8.4 CT
12.8.5 NUCLEAR IMAGING
12.8.6 OTHERS
12.9 DENTAL
12.9.1 X-RAY
12.9.2 MRI
12.9.3 ULTRASOUND
12.9.4 CT
12.9.5 NUCLEAR IMAGING
12.9.6 OTHERS
12.1 OTHERS
13 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 IMAGING CENTERS
13.4 SPECIALTY CLINICS
13.5 AMBULATORY SURGICAL CENTERS
13.6 ACADEMIC & RESEARCH INSTITUTES
13.7 OTHERS
14 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 THIRD PARTY DISTRIBUTOR
14.4 RETAIL SALES
15 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY GEOGRAPHY
MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.1 SAUDI ARABIA
15.2 UAE
15.3 QATAR
15.4 KUWAIT
15.5 ISRAEL
15.6 IRAN
15.7 IRAQ
15.8 NIGERIA
15.9 SOUTH AFRICA
15.1 EGYPT
15.11 ALGERIA
15.12 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, SWOT AND DBMR ANALYSIS
17 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS
17.2 MERGERS & ACQUISITIONS
17.3 NEW PRODUCT DEVELOPMENT & APPROVALS
17.4 EXPANSIONS
17.5 REGULATORY CHANGES
17.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
18 MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, COMPANY PROFILE
18.1 KONINKLIJKE PHILIPS N.V.
18.1.1 COMPANY OVERVIEW
18.1.2 REVENUE ANALYSIS
18.1.3 GEOGRAPHIC PRESENCE
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 SIEMENS HEALTHCARE GMBH
18.2.1 COMPANY OVERVIEW
18.2.2 REVENUE ANALYSIS
18.2.3 GEOGRAPHIC PRESENCE
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GE HEALTHCARE.
18.3.1 COMPANY OVERVIEW
18.3.2 REVENUE ANALYSIS
18.3.3 GEOGRAPHIC PRESENCE
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CARESTREAM HEALTH
18.4.1 COMPANY OVERVIEW
18.4.2 REVENUE ANALYSIS
18.4.3 GEOGRAPHIC PRESENCE
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 TELERADIOLOGY SOLUTIONS
18.5.1 COMPANY OVERVIEW
18.5.2 REVENUE ANALYSIS
18.5.3 GEOGRAPHIC PRESENCE
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 HOLOGIC, INC.
18.6.1 COMPANY OVERVIEW
18.6.2 REVENUE ANALYSIS
18.6.3 GEOGRAPHIC PRESENCE
18.6.4 PRODUCT PORTFOLIO
18.6.5 RECENT DEVELOPMENTS
18.7 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
18.7.1 COMPANY OVERVIEW
18.7.2 REVENUE ANALYSIS
18.7.3 GEOGRAPHIC PRESENCE
18.7.4 PRODUCT PORTFOLIO
18.7.5 RECENT DEVELOPMENTS
18.8 HITACHI, LTD.
18.8.1 COMPANY OVERVIEW
18.8.2 REVENUE ANALYSIS
18.8.3 GEOGRAPHIC PRESENCE
18.8.4 PRODUCT PORTFOLIO
18.8.5 RECENT DEVELOPMENTS
18.9 MEDTRONIC
18.9.1 COMPANY OVERVIEW
18.9.2 REVENUE ANALYSIS
18.9.3 GEOGRAPHIC PRESENCE
18.9.4 PRODUCT PORTFOLIO
18.9.5 RECENT DEVELOPMENTS
18.1 CANON MEDICAL SYSTEMS CORPORATION
18.10.1 COMPANY OVERVIEW
18.10.2 REVENUE ANALYSIS
18.10.3 GEOGRAPHIC PRESENCE
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPMENTS
18.11 SAMSUNG ELECTRONICS CO., LTD
18.11.1 COMPANY OVERVIEW
18.11.2 REVENUE ANALYSIS
18.11.3 GEOGRAPHIC PRESENCE
18.11.4 PRODUCT PORTFOLIO
18.11.5 RECENT DEVELOPMENTS
18.12 KARL STORZ SE & CO. KG
18.12.1 COMPANY OVERVIEW
18.12.2 REVENUE ANALYSIS
18.12.3 GEOGRAPHIC PRESENCE
18.12.4 PRODUCT PORTFOLIO
18.12.5 RECENT DEVELOPMENTS
18.13 STRYKER
18.13.1 COMPANY OVERVIEW
18.13.2 REVENUE ANALYSIS
18.13.3 GEOGRAPHIC PRESENCE
18.13.4 PRODUCT PORTFOLIO
18.13.5 RECENT DEVELOPMENTS
18.14 OLYMPUS
18.14.1 COMPANY OVERVIEW
18.14.2 REVENUE ANALYSIS
18.14.3 GEOGRAPHIC PRESENCE
18.14.4 PRODUCT PORTFOLIO
18.14.5 RECENT DEVELOPMENTS
18.15 CARL ZEISS AG
18.15.1 COMPANY OVERVIEW
18.15.2 REVENUE ANALYSIS
18.15.3 GEOGRAPHIC PRESENCE
18.15.4 PRODUCT PORTFOLIO
18.15.5 RECENT DEVELOPMENTS
18.16 SHIMADZU CORPORATION
18.16.1 COMPANY OVERVIEW
18.16.2 REVENUE ANALYSIS
18.16.3 GEOGRAPHIC PRESENCE
18.16.4 PRODUCT PORTFOLIO
18.16.5 RECENT DEVELOPMENTS
18.17 ALLENGERS
18.17.1 COMPANY OVERVIEW
18.17.2 REVENUE ANALYSIS
18.17.3 GEOGRAPHIC PRESENCE
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPMENTS
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY OVERVIEW
18.18.2 REVENUE ANALYSIS
18.18.3 GEOGRAPHIC PRESENCE
18.18.4 PRODUCT PORTFOLIO
18.18.5 RECENT DEVELOPMENTS
18.19 KONICA MINOLTA, INC.
18.19.1 COMPANY OVERVIEW
18.19.2 REVENUE ANALYSIS
18.19.3 GEOGRAPHIC PRESENCE
18.19.4 PRODUCT PORTFOLIO
18.19.5 RECENT DEVELOPMENTS
18.2 NP JSC AMICO
18.20.1 COMPANY OVERVIEW
18.20.2 REVENUE ANALYSIS
18.20.3 GEOGRAPHIC PRESENCE
18.20.4 PRODUCT PORTFOLIO
18.20.5 RECENT DEVELOPMENTS
18.21 STERNMED GMBH
18.21.1 COMPANY OVERVIEW
18.21.2 REVENUE ANALYSIS
18.21.3 GEOGRAPHIC PRESENCE
18.21.4 PRODUCT PORTFOLIO
18.21.5 RECENT DEVELOPMENTS
18.22 TRIVITRON HEALTHCARE
18.22.1 COMPANY OVERVIEW
18.22.2 REVENUE ANALYSIS
18.22.3 GEOGRAPHIC PRESENCE
18.22.4 PRODUCT PORTFOLIO
18.22.5 RECENT DEVELOPMENTS
18.23 PLANMED OY
18.23.1 COMPANY OVERVIEW
18.23.2 REVENUE ANALYSIS
18.23.3 GEOGRAPHIC PRESENCE
18.23.4 PRODUCT PORTFOLIO
18.23.5 RECENT DEVELOPMENTS
18.24 SONOSCAPE MEDICAL CORP.
18.24.1 COMPANY OVERVIEW
18.24.2 REVENUE ANALYSIS
18.24.3 GEOGRAPHIC PRESENCE
18.24.4 PRODUCT PORTFOLIO
18.24.5 RECENT DEVELOPMENTS
18.25 IDETEC MEDICAL IMAGING
18.25.1 COMPANY OVERVIEW
18.25.2 REVENUE ANALYSIS
18.25.3 GEOGRAPHIC PRESENCE
18.25.4 PRODUCT PORTFOLIO
18.25.5 RECENT DEVELOPMENTS
18.26 CEFLA S.C
18.26.1 COMPANY OVERVIEW
18.26.2 REVENUE ANALYSIS
18.26.3 GEOGRAPHIC PRESENCE
18.26.4 PRODUCT PORTFOLIO
18.26.5 RECENT DEVELOPMENTS
19 RELATED REPORTS
20 CONCLUSION
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
